Taking place from 6th - 7th March in North Bethesda, USA. 

Meet our attendees:

Meet David Johnson - Sales and Marketing Director

David Johnson is the Sales & Marketing Director for 3P Innovation, serving predominantly the Pharmaceutical sector 3P support their customers with custom engineering solutions together alongside a range of fill/finish liquid and powder technologies. Before joining 3P innovation David worked in the Oral Solid Dosage sector as a containment SME for a leading process equipment supplier. His experience in the Pharmaceutical world spans over 15 years and he remains committed to having a positive impact with the people and companies he works with. Haling from Rugby, UK, David is a rugby union fan and can always find justification to include a rugby story in any business situation.

Connect before the event? David Johnson | LinkedIn

Meet David Phasey - Engineering Director

David Phasey, joined 3P in 2010 as a Project Development Engineer joining a growing team to help develop automation for a novel healthcare device. In the subsequent 10 years, David has risen to Project Director, delivering projects across a spectrum of industries, each of which has contributed to the development of 3P's range of platform technologies. This breadth of experience has enabled David to develop a valuable set of capabilities across manufacturing processes such as novel vaccine delivery and ATMP's, with a specialist knowledge of sterile manufacturing.

Connect before the event? David Phasey | LinkedIn

 

Meet Tom French - Senior Project Engineer

Tom French is a project manager at 3P innovation Ltd, and is responsible for leading a team of engineers focused on medical device design and industrialization projects. Tom has experience working on a large number of device based projects with a range of multi-national clients, from concept ideation through to commercialisation, leading core design work on drug delivery devices and underlying process development. He is team lead on DfM/DfA consultancy for medical devices in the parenteral and inhaled space with a focus on injection moulded components, and is responsible for the process development, experimental design, testing and results analysis for a wide range of novel manufacturing processes. He has extensive powder filling experience with a large range of technologies across both the inhaled and injectables landscape.

Connect before the conference? Tom French | LinkedIn

 

Conference Overview: Taken from the ISPE Website

The need to take advantage of new technologies and explore new ways for process control and efficiency permeates all areas of pharmaceutical manufacturing. Recent emerging technologies in aseptic processing such as advanced isolators, robotics, and increased automation have changed the industry and reduced contamination risks for sterile products. Simultaneously, modern therapies - new, targeted approaches to treatment resulting in small-batch aseptic products - are proving more difficult to sterilize and handle and requiring faster speeds to market. Furthermore, the updated Annex 1 will impact the manufacture of sterile products, setting new requirements for Quality Risk Management, Contamination Control Strategy, and Data Management and Compliance for Computerized Systems. The requirement to re-think the existing standards is becoming more urgent.

Thus, as we slowly navigate to the post-COVID world and return to the new normal, ISPE’s Aseptic Conference wants to realign our focus. We welcome you to participate at the 2023 ISPE Aseptic Conference to learn and share progress, success stories, best practices and lessons learned. See you in North Bethesda, Maryland!